Multistep resistance development studies of ceftaroline in gram-positive and -negative bacteria.
about
No decrease in susceptibility to NVC-422 in multiple-passage studies with methicillin-resistant Staphylococcus aureus, S. aureus, Pseudomonas aeruginosa, and Escherichia coliCeftaroline fosamil: a brief clinical review.Missense mutations in PBP2A Affecting ceftaroline susceptibility detected in epidemic hospital-acquired methicillin-resistant Staphylococcus aureus clonotypes ST228 and ST247 in Western Switzerland archived since 1998The challenge of efflux-mediated antibiotic resistance in Gram-negative bacteria.[Resistance to "last resort" antibiotics in Gram-positive cocci: The post-vancomycin era].Study of Antibiotic Resistance Pattern in Methicillin Resistant Staphylococcus Aureus with Special Reference to Newer Antibiotic.Intrinsic and acquired resistance mechanisms in enterococcus.Critical appraisal of ceftaroline in the management of community-acquired bacterial pneumonia and skin infections.Ceftaroline fosamil for community-acquired bacterial pneumonia and acute bacterial skin and skin structure infection.Ceftaroline fosamil in the treatment of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections.In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010).Ceftaroline fosamil: a review of its use in the treatment of complicated skin and soft tissue infections and community-acquired pneumonia.Ceftaroline fosamil for the treatment of acute bacterial skin and skin structure infections.Ceftaroline Fosamil: A Review in Complicated Skin and Soft Tissue Infections and Community-Acquired Pneumonia.Use of Ceftaroline Fosamil in Children: Review of Current Knowledge and its Application.Identification of non-PBP2a resistance mechanisms in Staphylococcus aureus after serial passage with ceftaroline: involvement of other PBPs.Periprosthetic joint infections: clinical and bench research.
P2860
Q24627750-915B4125-D829-4588-AC5D-93B4602C819CQ33939080-78B52841-7D63-46D4-AB6D-98025F4A645AQ35169054-32781866-1091-4890-8A9A-77CE146EB160Q35482558-7ED27093-5539-43B5-A8D0-07DA8FCA9E58Q35619094-161AA05C-9F27-4180-944F-D2D0A8FF367AQ35663379-69477C4F-6076-4476-B0FC-5F9F3D9BD625Q36362547-D44CDFF3-A074-4573-AF3C-F293506BA03DQ38006689-8C58F08F-F219-4B98-8434-F9ADDE2A6E2DQ38010783-22C10886-0A6D-4127-82EE-3149057670CFQ38025132-BB78EA7C-C149-4AFD-B9BD-6696B02400F0Q38035808-2A0B1AB4-3694-4E66-A954-343CDE1D6F36Q38117077-21A4A2EE-2E4E-4A38-A498-470AF6D622BBQ38185097-9F348D54-211C-420C-AD18-C18B8C49FF1DQ38987098-FD8E22C6-2830-4367-AD45-56652744C81AQ39048083-F935BDD0-29DC-4DF6-B0FF-2CAE3987B98EQ40587085-F5CF0B68-AFEE-414B-B083-20DD35AF17C0Q53663173-9C98146A-86E0-4CEA-A629-B8CA317076F2
P2860
Multistep resistance development studies of ceftaroline in gram-positive and -negative bacteria.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Multistep resistance developme ...... sitive and -negative bacteria.
@en
Multistep resistance developme ...... sitive and -negative bacteria.
@nl
type
label
Multistep resistance developme ...... sitive and -negative bacteria.
@en
Multistep resistance developme ...... sitive and -negative bacteria.
@nl
prefLabel
Multistep resistance developme ...... sitive and -negative bacteria.
@en
Multistep resistance developme ...... sitive and -negative bacteria.
@nl
P2093
P2860
P356
P1476
Multistep resistance developme ...... sitive and -negative bacteria.
@en
P2093
Catherine Clark
Klaudia Kosowska-Shick
Pamela McGhee
Peter C Appelbaum
P2860
P304
P356
10.1128/AAC.01602-10
P407
P577
2011-02-22T00:00:00Z